CVA Family Office »

Moleculin Biotech shares owned by CVA Family Office

Quarter-by-quarter ownership of Moleculin Biotech (MBRX) shares owned by CVA Family Office from 13F filings

Historical chart of CVA Family Office investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by CVA Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by CVA Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $3 1 3.00

More positions owned by CVA Family Office

Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Fundamental Intl (FNDF)
Vanguard World Inf Tech Etf (VGT)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
American Centy Etf Tr Intl Eqt Etf (AVDE)
American Centy Etf Tr Us Eqt Etf (AVUS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Apple (AAPL)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Ishares Tr Core Us Aggbd Et (AGG)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Fundamental Emer (FNDE)

View all positions for CVA Family Office

Top funds holding Moleculin Biotech

Jane Street
Vanguard Group
Geode Capital Management
UBS Group
Tower Research Capital
BlackRock
EFG International
Pinnacle Wealth Planning Services
Rockefeller Capital Management
Newbridge Financial Services Group
SBI Securities
Danske Bank A/s
CVA Family Office
Advisor Group Holdings

View all funds holding Moleculin Biotech